Kazuaki Kameda
Overview
Explore the profile of Kazuaki Kameda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
236
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gomyo A, Kako S, Kawamura M, Kawamura S, Takeshita J, Yoshino N, et al.
Int J Hematol
. 2025 Feb;
PMID: 39912986
Rapid tapering of cyclosporine (CsA) in the early phase after allogeneic transplantation may induce a potent graft-versus-leukemia/lymphoma (GVL) effect. We retrospectively reviewed the outcomes of patients with high-risk hematological malignancies...
2.
Konuma T, Kameda K, Morita K, Kondo T, Kimura F, Nakasone H, et al.
Am J Hematol
. 2024 Nov;
100(1):66-77.
PMID: 39564683
We retrospectively evaluated the impacts of using granulocyte colony-stimulating factor (G-CSF) and its timing on posttransplant outcomes for 9766 adults with acute myeloid leukemia (AML) between 2013 and 2022 using...
3.
Kamakura T, Kameda K, Manabe M, Torii K, Sugiura Y, Ito S, et al.
Cell Death Discov
. 2024 Jul;
10(1):322.
PMID: 38997262
Some RNAs such as 28S rRNA, U1 small nuclear RNA (snRNA), and Y RNAs are known to be cleaved during apoptosis. The underlying mechanism, functions, and biological significance of RNA...
4.
Yoshino N, Kimura S, Kawamura K, Nakata Y, Matsuoka A, Ishikawa T, et al.
J Infect Chemother
. 2024 Jun;
31(1):102455.
PMID: 38925426
Background: A change in empirical antibiotics or the addition of glycopeptide antibiotics is often applied in cases of persistent febrile neutropenia (FN) despite the administration of broad-spectrum antibiotics. However, the...
5.
Yanagiya R, Miyatake Y, Watanabe N, Shimizu T, Kanamori A, Ueno M, et al.
Leukemia
. 2024 Jun;
38(8):1731-1741.
PMID: 38914715
Aggressive natural killer cell leukemia (ANKL) is a rare hematological malignancy with a fulminant clinical course. Our previous study revealed that ANKL cells proliferate predominantly in the liver sinusoids and...
6.
Oh I, Hatano K, Ikeda T, Toda Y, Minakata D, Kawaguchi S, et al.
Leuk Res
. 2024 Jan;
137:107438.
PMID: 38278044
No abstract available.
7.
Gomyo A, Kimura S, Suzuki J, Ishikawa T, Meno T, Matsuoka A, et al.
Transplant Cell Ther
. 2023 Aug;
29(11):721.e1-721.e8.
PMID: 37643718
Clinical research regarding the impact of pretransplantation physical function on transplantation outcomes in older adults remains limited. We retrospectively reviewed the charts of 150 consecutive patients age >55 years who...
8.
Matsumi S, Kimura S, Nakamura Y, Kawamura M, Takeshita J, Kawamura S, et al.
Int J Hematol
. 2023 Jul;
118(4):450-461.
PMID: 37480446
Combination of calcineurin inhibitors (CIs) with short-term methotrexate is a standard prophylactic regimen for graft-versus-host disease (GVHD). However, it is sometimes difficult to continue CIs due to adverse effects, such...
9.
Kameda K, Yanagiya R, Miyatake Y, Carreras J, Higuchi H, Murayama H, et al.
Blood
. 2023 May;
142(4):352-364.
PMID: 37146246
Aggressive natural killer cell leukemia (ANKL) is a rare lymphoid neoplasm frequently associated with Epstein-Barr virus, with a disastrously poor prognosis. Owing to the lack of samples from patients with...
10.
Nakamura Y, Kawamura S, Matsumi S, Matsumoto K, Tanaka S, Ishikawa T, et al.
Rinsho Ketsueki
. 2023 Apr;
64(4):250-254.
PMID: 37121767
A 34-year-old man with KMT2A-MLLT1 acute myeloid leukemia in first complete remission underwent allogeneic peripheral blood stem cell transplantation from his HLA-matched sister after conditioning with busulfan/cyclophosphamide. He did not...